BAQSIMI
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for BAQSIMI, covering 2019-07-24 to 2025-09-15. Get the full timeline:
Most recent: EMA Authorised: Baqsimi (Glucagon) — Amphastar France Pharmaceuticals